Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Double surgery combo may help glaucoma patients see better outcomes

NCT ID NCT07073937

First seen Jan 11, 2026 · Last updated Jun 19, 2026 · Updated 26 times

Summary

This study reviews 100 patients with open-angle glaucoma who had two minimally invasive surgeries (Hydrus microstent and iTrack canaloplasty) along with cataract surgery. Researchers want to see if this combination lowers eye pressure and reduces the need for glaucoma medications over three years. The goal is to find a more effective surgical approach for managing glaucoma.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GLAUCOMA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • University of Utah John A. Moran Eye Center

    Salt Lake City, Utah, 84132, United States

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Hydrus microstent and iTrack canaloplasty (surgical procedures)

What this could lead to

If successful, this could show that combining these two surgeries is more effective at lowering eye pressure and reducing medication use than cataract surgery alone.

What could go wrong

This is a small, retrospective chart review, not a controlled trial. Results may not apply to all patients, and the study cannot prove cause and effect.

Conditions

The condition(s) this trial relates to.

glaucoma ocular hypertension open-angle glaucoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.